Ana De Juan

Mutations in BRIP1 confer high risk of ovarian cancer

Daníel F. Guðbjartsson, Patrick Sulem, Áslaug Jónasdóttir et al. · Nature Genetics · 2011 · 427 citations

Medicine, Genetics, Molecular Genetics +11

Deletions Affecting Codons 557-558 of the <i>c</i>-<i>KIT</i> Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)

Javier Martín‐Broto, Andrés Poveda, Antonio Llombart‐Bosch et al. · Journal of Clinical Oncology · 2005 · 350 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells

Pedro J. Real, Àngels Sierra, Ana De Juan et al. · Oncogene · 2002 · 321 citations

Medicine, Cancer Biology, Oncology +14

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

Simon Stacey, Patrick Sulem, Áslaug Jónasdóttir et al. · Nature Genetics · 2011 · 304 citations · Full text

Medicine, Genetics, Molecular Genetics +12

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Xavier García del Muro, Antonio López–Pousa, Joan Maurel et al. · Journal of Clinical Oncology · 2011 · 298 citations

Medicine, Oncology, Pharmacotherapy +12